Amal Wahhab

This inventor holds 8 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 2 EPO patents. Top assignees: Hoffmann-La Roche Inc., Methylgene, Inc., Cyclenium Pharma Inc.. Active years: 2010-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amal Wahhab. Retrieved from https://idiyas.com/inventor/amal-wahhab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 3)

% Patents Active = 62.5

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 8.1

ph-index = 3

Forward Citations = 44(Granted Patents)

Company Filing History:

3 out of 5,026

Hoffmann-La Roche Inc.

Cyclenium Pharma Inc.

patents

Years Active: 2010-2024

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12012466 - Peptide macrocycles against (2024-06-18),

2. 11098080 - Peptide macrocycles against Acinetobacter baumannii (2021-08-24),

3. 10981931 - Libraries of heteroaryl-containing macrocyclic compounds and methods of making and using the same (2021-04-20),

4. 10407442 - Libraries of heteroaryl-containing macrocyclic compounds and methods of making and using the same (2019-09-10),

5. 10030047 - Peptide macrocycles against acinetobacter baumannii (2018-07-24),

6. 8470850 - Inhibitors of VEGF receptor and HGF receptor signalling (2013-06-25),

7. 8338437 - Amines as small molecule inhibitors (2012-12-25),

8. 7772247 - Substituted thieno[3,2-d]pyridines as inhibitors of the VEGF receptor and HGF receptor (2010-08-10),

Title: Amal Wahhab: Innovator in Peptide Macrocycles

Introduction

Amal Wahhab is a distinguished inventor based in Laval, Canada. She has made significant contributions to the field of biotechnology, particularly in the development of peptide macrocycles. With a total of eight patents to her name, her work has garnered attention for its potential applications in combating bacterial infections.

Latest Patents

Among her latest patents, Amal has developed compounds of formula (I) that target Acinetobacter baumannii. These peptide macrocycles represent a promising avenue for addressing antibiotic resistance, showcasing her innovative approach to solving pressing health challenges.

Career Highlights

Throughout her career, Amal has worked with notable companies such as Methylgene, Inc. and Hoffmann-La Roche Inc. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Amal has collaborated with esteemed colleagues, including Dwight MacDonald and Helmut Thomas. These partnerships have enriched her research and expanded the impact of her inventions.

Conclusion

Amal Wahhab's contributions to the field of biotechnology through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in medical science.

Profile summary based on public USPTO records.